MMP-9 Inhibition by ACE Inhibitor Reduces Oxidized LDL-Mediated Foam-Cell Formation
-
- Kojima Chiari
- Life Science and Bioethics Research Center, Tokyo Medical and Dental University. Department of Internal Medicine IV, Tokyo Women's Medical University.
-
- Ino Jun
- Life Science and Bioethics Research Center, Tokyo Medical and Dental University. Department of Internal Medicine IV, Tokyo Women's Medical University.
-
- Ishii Hideto
- Life Science and Bioethics Research Center, Tokyo Medical and Dental University.
-
- Nitta Kosaku
- Department of Internal Medicine IV, Tokyo Women's Medical University.
-
- Yoshida Masayuki
- Life Science and Bioethics Research Center, Tokyo Medical and Dental University.
この論文をさがす
抄録
Aim: Angiotensin-converting enzyme inhibitors (ACEIs) have been shown to block matrix metalloproteinase (MMP)-9 activity, which plays a role in atherogenesis. MMP-9 activity of macrophages is increased during foam cell formation. To investigate the contribution of ACEIs to foam cell formation, we studied the effects of an ACEI, imidaprilat, on THP-1 macrophages and the underlying molecular mechanisms in vitro.<BR>Methods and Results: Pre-treatment of THP-1 macrophages with imidaprilat (100 nmol/L, 4 hours) significantly decreased foam cell formation induced by oxidized LDL (OxLDL). Imidaprilat reduced the protein level of MMP-9 in THP-1 macrophages and attenuated OxLDL-induced MMP-9 activity in the culture supernatants. Indeed, pretreatment of THP-1 macrophages with an MMP-2/9 inhibitor (20 µmol/L, 4 hours) attenuated OxLDL-induced foam-cell formation. Imidaprilat or the MMP-2/9 inhibitor blocked OxLDL-induced expressions of LOX-1 and scavenger receptor-A (SR-A), but not that of CD36, in THP-1 macrophages. In addition, OxLDL-induced activation of p38 mitogen-activated protein kinase (MAPK) and ERK, but not JNK, was blunted by imidaprilat or the MMP-2/9 inhibitor. Finally, siRNA against MMP-9 inhibited foam cell formation as well as lipid accumulation in THP-1 macrophages.<BR>Conclusion: These findings suggest that imidaprilat reduces OxLDL-triggered foam-cell formation in THP-1 macrophages via modulation of MMP-9 activity and may indicate a novel antiinflamma-tory mechanism of imidaprilat in atherogenesis.
収録刊行物
-
- Journal of Atherosclerosis and Thrombosis
-
Journal of Atherosclerosis and Thrombosis 17 (1), 97-105, 2010
一般社団法人 日本動脈硬化学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282679409296640
-
- NII論文ID
- 130004444376
-
- DOI
- 10.5551/jat.1685
-
- ISSN
- 18803873
- 13403478
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可